MDI and DPI Drug Products
...Documentation in Drug Applications for Container and Closure Systems Used for the.....program because they can affect the ability of the product to deliver reproducible doses.....The guidance sets forth information that should be provided to ensure continuing drug..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....used if such approach satisfies the requirements of the applicable statutes and.....made to verify that the correct label has been affixed to the container and the shield..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=98)

PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Critical activities in the production and testing of a PET drug product that expose the PET drug product or the sterile surface.....A string label can be used by PET centers to label the immediate container provided that there is a way to associate the label with.....A batch of a PET drug product is a predefined quantity of the drug that has been produced to..
http://www.fda.gov/cder/guidance/4259dft.htm (score=94)

þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....its specification and, therefore, can be used in the manufacture of a given drug product.....A description of the container closure system for the drug substance should be provided..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=91)

þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....its specification and, therefore, can be used in the manufacture of a given drug product.....A description of the container closure system for the drug substance should be provided..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=87)

GUIDE TO INSPECTIONS OF BULK PHARMACEUTICAL CHEMICALS
...It would be unrealistic to expect drug product GMP concepts to apply to the production of these.....a substance that is represented as a drug and, when used, becomes an active ingredient or finished dosage.....container, or is transported without containerization to a location for subsequent..
http://www.fda.gov/ora/inspect_ref/igs/bulk.html (score=87)

Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and.....same areas used to produce the drug substance that is the subject of this application.....A description of the container and closure system, and its compatibility with the drug..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=85)

Document
...number in this manner would, code requirement, and we consider drug doses of the drug.....drugs are used in hospitals, so bar codes errors involving radiopharmaceuticals, bar codes.....manufacturer, product, and package. prevent the introduction, transmission, drug product..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04-4249.pdf (score=84)

stability guidance -draft
...If testing of the drug product in the immediate container or as marketed is needed, the samples.....and the test methods used to monitor the stability of the drug product packaged in the.....Where the same strength and exact container/closure system is used for three or more fill..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=79)

GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS
...An alternative approach may be used if such..approach satisfies the requirements of the.....This draft guidance, when finalized, will represent the Food and Drug Administration=s.....product-related frequencies, and severity with a view to taking additional, 1360.. and if..
http://www.fda.gov/cder/guidance/4011dft.pdf (score=77)

...To ensure that a botanical drug product used in clinical trials is of consistently good quality, and.....A description of the container/closure in which the botanical drug substance is to be.....A chemical constituent of a botanical raw material, drug substance, or drug product that is used for identification and/or quality..
http://www.fda.gov/cder/guidance/4592fnl.doc (score=74)

Las Vegas Injury Lawyer